Nord D
MMW Munch Med Wochenschr. 1977 Aug 26;119(34):1075-8.
Proceeding from the arguments of a recent publication, an attempt is made to establish whether a monocausal assessment is fruitful in the explanation of the development of drug costs in the statutory health insurance. The question is raised whether the price increase for drugs is in fact the decisive variable determining the costs. This is denied on the grounds of a differential analysis of the causative variables involved and it is shown what role, besides price and quantity components, the innovation or structure effect plays in the development of drug costs.
基于最近一篇出版物的观点，我们尝试确定单因素评估对于解释法定医疗保险中药品费用增长是否有效。我们提出这样一个问题：药品价格上涨是否实际上是决定成本的关键变量。基于对相关因果变量的差异分析，我们对此予以否定，并表明除了价格和数量因素外，创新或结构效应在药品费用增长中所起的作用。
